|
|
||||||||
The Journal of Immunology, Vol 136, Issue 12 4503-4508, Copyright © 1986 by American Association of Immunologists
ARTICLES |
K Grabstein, S Dower, S Gillis, D Urdal and A Larsen
Human peripheral blood T lymphocytes were treated with recombinant interleukin 2, mitogens, and dexamethasone. The resulting accumulation of mRNA for interleukin 2 (IL 2), the interleukin 2 receptor (IL 2R), and interferon-gamma (IFN-gamma) was measured. IL 2 was found to regulate the levels of each of these mRNA. The expression of mRNA for IL 2, IL 2R, and IFN-gamma correlated very well with the levels of protein observed. In populations of peripheral blood T lymphocytes, the production of IL 2 and IFN-gamma were not necessarily coordinately expressed. The sequential expression of these mRNA was investigated in order to determine whether they might be independent of the action of IL 2. IFN-gamma and IL 2 mRNA showed biphasic accumulations. IL 2 mRNA accumulated very rapidly, within 60 min after mitogen stimulation and before any detectable IL 2R mRNA accumulation. Similarly, IFN-gamma mRNA accumulated rapidly, simultaneously with IL 2 mRNA. This early peak of IFN-gamma mRNA, therefore, is likely to be independent of IL 2 action. Both IL 2 and IFN-gamma mRNA then showed later peak times of accumulation. IL 2 mRNA levels peaked at 5 hr after mitogen stimulation, whereas IFN-gamma mRNA levels peaked at 20 hr. IL 2R mRNA continued to accumulate for the full 40 hr of these kinetic experiments. The later accumulations of IFN-gamma and IL 2R mRNA and the resulting expression of the corresponding proteins may therefore be dependent on the earlier production of IL 2 and its subsequent interaction with the IL 2R on the surface of such activated T cells.
This article has been cited by other articles:
![]() |
A. Kato, H. Kimura, K. Okabe, J. Okabe, N. Kunou, and Y. Ogura Feasibility of Drug Delivery to the Posterior Pole of the Rabbit Eye with an Episcleral Implant Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okabe, H. Kimura, J. Okabe, A. Kato, N. Kunou, and Y. Ogura Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery Device Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2702 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Okabe, H. Kimura, N. Kunou, K. Okabe, A. Kato, and Y. Ogura Biodegradable Intrascleral Implant for Sustained Intraocular Delivery of Betamethasone Phosphate Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 740 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. McFadden Jr. Inhaled Glucocorticoids and Acute Asthma . Therapeutic Breakthrough or Nonspecific Effect? Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 677 - 678. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |